Wintermute: Severe "inventory shortage" issue occurred in the DeFi market during the "10.11" crash event
BlockBeats reported on October 20 that Evgeny Gaevoy, founder of crypto market maker Wintermute, stated during The Block's podcast that, "During the '10.11' crash, there was a serious inventory issue in the DeFi market. Our positions were on a certain exchange, but we couldn't transfer them out, so we sold everything we could on DeFi, and bought everything we could on that exchange, but couldn't complete the asset transfer, resulting in a liquidity imbalance."
Gaevoy said that although arbitrage could be done through lending or cross-market pricing, the risks were high and the operations were complex. In this incident, many competitors' risk control systems triggered circuit breakers and suspended DeFi trading. Nevertheless, he expressed satisfaction with his team's performance, saying, "Although we could have made more money, we did indeed run out of inventory."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
